IQVIA™ Real-World Insights Bibliography
Effectiveness and safety of empagliflozin in routine care in Europe and East Asia: results from
the empagliflozin comparative effectiveness and safety (EMPRISE) study
|
Author(s): A. Karasik1
, S. Lanzinger2
, E. Chia-Hui Tan3
, D. Yabe4
, D. Jung Kim5
, W. H-H Sheu6
, C. MelzerCohen1
, R.W. Holl2
, K. Ha5
, T. Nyström7
, L. Niskanen8
, M. Linnemann Jensen9
, M.H. Kyaw10, J.
Núñez11, EMPRISE EU and East Asia Study Group; |
Affiliations(s): Maccabi Research & Innovation Center, Tel Aviv University, Tel Aviv, Israel, 2
Inst. for
Epidemiology & Medical Biometry, Uni. of Ulm, Ulm, Germany, 3National Research Inst. of Chinese
Medicine, Taipei, Taiwan, 4Dept. of Diabetes and Endocrinology, Gifu University Graduate School of
Medicine, Gifu, Japan, 5Dept. of Endocrinology & Metabolism, Ajou Uni. School of Medicine,
Suwon, Republic of Korea, 6Taipei Veterans General Hospital, Taipei, Taiwan, 7Dept. of Clinical
Science & Education, Södersjukhuset, Karolinska Institutet, Solna, Sweden, 8Department of Medicine,
Päijät-Häme Central Hospital, Lahti, Finland, 9
IQVIA, Copenhagen, Denmark, 10Boehringer
Ingelheim Pharmaceutical Inc., Ridgefield, USA, 11Dept. of Cardiology, Hospital Clínico
Universitario de Valencia, Valencia, Spain |
Publication(s):
https://doi.org/10.2337/DB21-127-LB Virtual EASD 2021, 57 Annual Meeting, 27 September - 10 October 2021
|
Document Type(s): Abstract, |
Countries: Finland, Germany, Israel, Japan, South Korea, Spain, Sweden, Taiwan, |
Click here for the abstract |
C: Y: |
Cardiovascular disease, Diabetes, 2021 |
|
L: A: |
English Database Study, Methodology, Population Based Study, |
|
|
|
|
Cardiovascular Effectiveness of Empagliflozin Compared to DPP-4i in Routine Care in East Asia: Results from the EMPRISE study |
Author(s): Dae Jung Kim, Wayne H.-H. Sheu, Wook-Jin Chung, Daisuke Yabe, Kyoung Hwa Ha, Elise Chia-Hui Tan, Yusuke Taneda, Vanessa Lei, Laura Saarelainen, Anouk Deruaz-Luyet, Moe H. Kyaw, Yutaka Seino, EMPRISE East Asia Study Group, Boehringer Ingelheim International GmbH, Ingelheim, Germany, StatFinn - EPID Research an IQVIA Company, Espoo, Finland |
Affiliations(s): 1 Ajou University, Suwon, South Korea; 2 Taichung Veterans General Hospital, Taichung, Taiwan; 3 Gachon University Gil Medical Center, Incheon, South Korea; 4 Kansai Electric Power Medical Research Institute, Kobe, Japan; 5 Gifu University Graduate School of Medicine, Gifu, Japan; 6 National Research Institute of Chinese Medicine, Taipei, Taiwan; 7 Nippon Boehringer Ingelheim Co. Ltd., Tokyo, Japan; 8 Boehringer Ingelheim Taiwan Ltd., Taipei, Taiwan; 9 IQVIA, Espoo, Finland; 10 Boehringer Ingelheim International GmbH, Ingelheim, Germany; 11 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA; 12 Kansai Electric Power Hospital, Osaka, Japan |
Publication(s): J Am Coll Cardiol. 2021 May, 77 (18_Supplement_1) 542.
https://doi.org/10.1016/S0735-1097(21)01901-X
|
Document Type(s): Abstract, Presentation, |
Countries: Japan, South Korea, Taiwan, |
Click here for the abstract |
C: Y: |
Cardiovascular disease, Diabetes, 2021 |
|
L: A: |
English Database Study, Methodology, Observational study, |
|
|
|
|
Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study |
Author(s): Yutaka Seino*, Dae Jung Kim, Daisuke Yabe, Elise Chia-Hui Tan, Wook-Jin Chung, Kyoung Hwa Ha, Masaomi Nangaku, Koichi Node, Riho Klement**, Atsutaka Yasui, Wei-Yu, Sunwoo Lee, Moe H Kyaw, Anouk Deruaz-Luyet, Kimberly G Brodovicz,Wayne H-H Sheu, on behalf of the EMPRISE East Asia study group |
Affiliations(s): * Kansai Electric Power Medical Research Institute, Kobe, Japan and Kansai Electric Power Hospital, Osaka, Japan **EPID Research an IQVIA company, Tartu, Estonia |
Publication(s): Endocrinology, Diabetes and Metabolism 2020;00:e00183
|
Document Type(s): Article, |
Countries: Japan, South Korea, Taiwan, |
Click here for the abstract |
C: Y: |
Cardiovascular disease, Diabetes, 2020 |
|
L: A: |
English Epidemiological study, Retrospective database analysis, |
|
|
|
|
Cross-sectional study estimating the psychosocial impact of genital warts and other anogenital diseases in South Korea |
Author(s): Lee TS1, Kothari-Talwar S2, Singhal PK2, Yee K3, Kulkarni A2, Lara N4, Roset M4, Giuliano AR5, Garland SM6, Ju W7 |
Affiliations(s): 1 Department of Obstetrics and Gynecology, SMG-SNU Boramae Medical Center, Seoul, South Korea 2 Merck and Co Inc, Kenilworth, NJ, US 3 Cubist Pharmaceuticals Inc, Lexington, MA, US 4 IQVIA, Barcelona, Spain 5 Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, US 6 Microbiology and Infectious Diseases Department, The Royal Women's Hospital, Parkville, Victoria, Australia 7 School of Medicine, Ewha Womans University, Seoul, South Korea |
Publication(s): BMJ Open. 2019 Mar 20;9(3):e025035
|
Document Type(s): Article, |
Countries: South Korea, |
Click here for the abstract |
C: Y: |
Infectious disease, 2019 |
|
L: A: |
English Burden of illness, Clinical setting: Primary care, clinical setting: Secondary care, |
|
|
|
|
Profiling and treatment patterns in NSCLC patients with CNS (brain) metastases in Europe and Asia |
Author(s): Mari E1, Mpima S2, Guglielmetti F1, Nasuti P2, Manuguid F2, Heitner Enschede S3 |
Affiliations(s): 1IQVIA , Milan, Italy 2IQVIA , London, UK 3IQVIA Inc, USA |
Publication(s): |
Document Type(s): |
Countries: China, France, Germany, Italy, Japan, South Korea, Spain, UK, |
Click here for the abstract |
C: Y: |
2018 |
|
L: A: |
English
|
|
|
|
|
Patterns of care and of biomolecular characterization of Right, Transverse, and Left Colorectal Cancer from real-life evidence in Asia Pacific and European countries |
Author(s): Ettore M1, Mpima S2, Guglielmetti F1, Nasuti P2 |
Affiliations(s): 1IQVIA , Milan, Italy 2IQVIA , London, UK |
Publication(s): ESMO 2018
|
Document Type(s): Poster, |
Countries: China, France, Germany, Italy, Japan, South Korea, Spain, UK, |
Click here for the abstract |
C: Y: |
Oncology, 2018 |
|
L: A: |
English
|
|
|
|
|
Patterns of Therapy in Regional Lymph Node Positive Prostate Cancer in Europe and Asia: An International Analysis |
Author(s): Prentice M1, Mpima S2, Martinez de Pinillos A2, Nasuti P2, Davda R, Payne H 1 |
Affiliations(s): 1 University College Hospital, London, UK 2 IQVIA , London, UK |
Publication(s): ESMO 2018
|
Document Type(s): Poster, |
Countries: China, France, Germany, Italy, Japan, South Korea, Spain, UK, |
Click here for the abstract |
C: Y: |
Oncology, 2018 |
|
L: A: |
English
|
|
|
|
|
Initial Management of localised prostate cancer in the Elderly: An International Data Review |
Author(s): Prentice M1, Mpima S2, Martinez de Pinillos A2, Nasuti P2, Davda R1, Payne H1 |
Affiliations(s): 1 University College Hospital, London, UK 2 IQVIA , London, UK
|
Publication(s): SIOG 2018
|
Document Type(s): Poster, |
Countries: China, France, Germany, Italy, Japan, South Korea, Spain, UK, |
C: Y: |
Oncology, 2018 |
|
L: A: |
English
|
|
|
|
|
Profiling and treatment patterns in NSCLC patients with CNS (brain) metastases in Europe and Asia |
Author(s): Mari E1, Mpima S2, Guglielmetti F1, Nasuti P2, Manuguid F2, Heitner Enschede S3 |
Affiliations(s): 1IQVIA , Milan, Italy 2IQVIA , London, UK 3IQVIA Inc, USA |
Publication(s): JCO ( ASCO 2018)
|
Document Type(s): Abstract, |
Countries: Asia Pacific, China, Europe, France, Germany, Italy, Japan, South Korea, Spain, UK, |
Click here for the abstract |
C: Y: |
Oncology, 2018 |
|
L: A: |
English
|
|
|
|
|
The cost-effectiveness of travoprost preserved with polyquad® in newly treated open-angle glaucoma patients in 7 Asian countries. |
Author(s): Gerlier L1, Lamotte M1, Caputo J2, Tan R3 |
Affiliations(s): 1 IMS Health Consulting EMEA, Vilvoorde, Belgium 2 IMS Health Consulting Asia-Pacific, Singapore 3 ALCON, Asia-Pacific, Singapore |
Publication(s): 5th ISPOR Asia-Pacific Conference, 2012, September 2-4, Taipei, Taiwan
|
Document Type(s): Abstract, Poster, |
Countries: India, Malaysia, Singapore, South Korea, Thailand, |
C: Y: |
Ophthalmology, 2012 |
|
L: A: |
English Cost effectiveness, |
|
|
|
|
1 of 2
|
|